Characterisation of phenotypes based on severity of emphysema in chronic obstructive pulmonary disease. - Wikidata - awgldk - TriplyDB

Characterisation of phenotypes based on severity of emphysema in chronic obstructive pulmonary disease.

Characterisation of phenotypes based on severity of emphysema in chronic obstructive pulmonary disease.

http://www.wikidata.org/entity/Q36225516

about

Oxidative stress and free radicals in COPD--implications and relevance for treatment Quantitative computed tomography imaging in chronic obstructive pulmonary disease Real-world clinical data identifies gender-related profiles in chronic obstructive pulmonary disease.Relationship between peripheral airway function and patient-reported outcomes in COPD: a cross-sectional study.Cluster analysis in severe emphysema subjects using phenotype and genotype data: an exploratory investigation Polymorphism of SERPINE2 gene is associated with pulmonary emphysema in consecutive autopsy cases Efficacy, safety and pharmacokinetics of indacaterol in Caucasian and Japanese patients with chronic obstructive pulmonary disease: a comparison of data from two randomized, placebo-controlled studies.Surveillance of chronic obstructive pulmonary disease in high-risk individuals by using regional lung cancer mass screening.Effects of air pollution and seasons on health-related quality of life of Mongolian adults living in Ulaanbaatar: cross-sectional studies.Long-term variability of desmosine/isodesmosine as biomarker in alpha-1-antritrypsin deficiency-related COPD.Non-emphysematous chronic obstructive pulmonary disease is associated with diabetes mellitus Effect of emphysema on lung cancer risk in smokers: a computed tomography-based assessment.Predictors of pulmonary function response to treatment with salmeterol/fluticasone in patients with chronic obstructive pulmonary disease Opportunities and challenges in the genetics of COPD 2010: an International COPD Genetics Conference report.Effect of lung volume on airway luminal area assessed by computed tomography in chronic obstructive pulmonary disease.Equating quantitative emphysema measurements on different CT image reconstructions.Use of cluster analysis to describe desaturator phenotypes in COPD: correlations between pulmonary function tests and nocturnal oxygen desaturation PHYSIOLOGIC AND QUANTITATIVE COMPUTED TOMOGRAPHY DIFFERENCES BETWEEN CENTRILOBULAR AND PANLOBULAR EMPHYSEMA IN COPD.The reasons for triple therapy in stable COPD patients in Japanese clinical practice.How Common Is Airflow Limitation in Patients With Emphysema on CT Scan of the Chest?Determinants of chronic obstructive pulmonary disease severity in the late-elderly differ from those in younger patients.Role of Lung Function Genes in the Development of Asthma Diffusion-weighted hyperpolarized 129Xe MRI in healthy volunteers and subjects with chronic obstructive pulmonary disease Strategies to decrease ongoing oxidant burden in chronic obstructive pulmonary disease.Patients with severe emphysema have a low risk of radiation pneumonitis following stereotactic body radiotherapy.The regional association between bronchiectasis and lung cancer in chest CT.Long-term effects of gastrectomy in patients with spirometry-defined COPD and patients at risk of COPD: a case-control study.Arterial stiffness is independently associated with emphysema severity in patients with chronic obstructive pulmonary disease.Association of blood eosinophils and plasma periostin with FEV1 response after 3-month inhaled corticosteroid and long-acting beta2-agonist treatment in stable COPD patients.A challenge to the seven widely believed concepts of COPD.Characteristics of stable chronic obstructive pulmonary disease patients in the pulmonology clinics of seven Asian cities.Chronic obstructive pulmonary disease: lobe-based visual assessment of volumetric CT by Using standard images--comparison with quantitative CT and pulmonary function test in the COPDGene study.CT metrics of airway disease and emphysema in severe COPD.Targeted treatment in COPD: a multi-system approach for a multi-system disease.Antioxidant therapeutic advances in COPD.Computer quantification of airway collapse on forced expiration to predict the presence of emphysema.Body height as risk factor for emphysema in COPD.Genetics of chronic obstructive pulmonary disease: a succinct review, future avenues and prospective clinical applications.Quantitative CT measurement of cross-sectional area of small pulmonary vessel in COPD: correlations with emphysema and airflow limitation Factors associated with bronchiectasis in patients with moderate-severe chronic obstructive pulmonary disease.

P2860

Q26830076-C9FC35D3-1C37-4EDF-A0D7-F24A759CE9E9 Q28067775-48C8E7C6-5F06-4BFE-9B7D-E3ECD1D2B4F9 Q33509145-481A9C0A-10DE-4EF6-B83C-735CED5BBF88 Q33537468-B41435AA-626A-4902-B73A-D1B2AB359FA5 Q33541285-7877464C-BAA0-47B6-8561-4EDAB52C2CF7 Q33743565-D36F3084-FDA3-44F1-853F-2590A7F9D24A Q33780109-383D3278-4926-4985-A7AE-F33E90531F3C Q33821875-766DB245-FB35-4360-8B72-138B7CDC58A2 Q33827491-751A25DF-9487-436D-96D8-0B32AA03EAF5 Q33972919-5A76BF6A-BB29-4C13-ADFA-504245E2BCEF Q34436462-7B286B2B-6501-4F80-AD1E-12CBA0E89D7F Q34476776-BF0806A7-282F-40A0-98BB-D279D8993D1A Q34634754-3A7C3970-30F2-4008-B5F7-497F51B62CC9 Q34854354-8C78B1B8-5C93-413D-8A84-1E923190656B Q35108609-F8B3A648-9013-41E5-B6E1-2BCA7F332205 Q35191779-FF741C7C-B886-4063-BD86-4F56A16AFFE7 Q35574530-05085215-D75B-4A3F-A20B-1047E044C7FE Q35659735-17912295-3F30-4552-87CF-41BF78E67E58 Q35703852-6CE84E7A-EA1F-4927-998A-D0ABDB4A9B45 Q35825599-DC05EF49-A126-4C79-B5D9-3371ED36189D Q35884573-16BBFD99-7164-42FF-A313-DF967ECEBABD Q35890486-32FE48E7-EA5D-4414-B533-2FEB4FFE8233 Q35956386-0442CED0-940B-4433-AE8F-36DC400D43BD Q36036223-6D568920-E746-4E13-A8BA-99FF02D5ADC8 Q36187150-CD7B8626-5E18-4908-81FE-88CC24A24EB0 Q36193419-9AF53942-5DD2-47E8-8BF8-936C2A05ECD9 Q36244232-56C4678C-1326-4DE4-9FD5-3CAF8C4C3F7D Q36330612-06A736D0-50CC-429B-BCC9-A333F60D66AE Q36412702-AB20E928-3EFB-4073-A7D2-4278AEB4F48D Q36558218-07E961A9-53BA-4878-9F12-F409F7292B8E Q36558243-BB47BB41-5034-463D-A199-55907135EDC3 Q36573397-2BFB7AAB-99CA-4212-A8DF-7F3CC8872DC7 Q37323723-EA22140E-CB0A-4AED-A224-B42A8888C940 Q37340178-8B603106-F2F9-41EF-B1BB-A49A51BBD2FA Q37348279-DB461748-A274-409F-ADDE-13185F20AE19 Q37410076-AEB4C772-7C89-4615-8385-D6D713AD1C6F Q37428210-D3495B21-72E2-4557-9C21-36D45D921E2F Q37448915-06163B8B-4E38-45BB-886B-23209C52878C Q37466082-8FB99DD7-6263-4027-AC64-9B26266BD244 Q37605432-06C99B55-0826-4262-A77F-6A0C7178BCDA

P2860

Characterisation of phenotypes based on severity of emphysema in chronic obstructive pulmonary disease.

http://www.wikidata.org/entity/Q36225516

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Characterisation of phenotypes ...... obstructive pulmonary disease.

@ast

Characterisation of phenotypes ...... obstructive pulmonary disease.

@en

type

label

Characterisation of phenotypes ...... obstructive pulmonary disease.

@ast

Characterisation of phenotypes ...... obstructive pulmonary disease.

@en

prefLabel

Characterisation of phenotypes ...... obstructive pulmonary disease.

@ast

Characterisation of phenotypes ...... obstructive pulmonary disease.

@en

P1433

Q36225516-0272E46A-5786-4C57-80DC-4ECBEE896559

P1476

Q36225516-369C998F-0AE4-414F-9072-E3B40FB4AE20

P2093

Q36225516-0EB42307-261E-4737-AF5E-80C37E431D87

Q36225516-1327F91D-CE8B-4054-8DC2-371CBBE45343

Q36225516-50360482-1377-4900-A57C-1472C656F919

Q36225516-55FFC858-CDC1-4BC3-B5CA-AE2E15BA9081

Q36225516-56B5F05E-3023-4119-A60C-29C68B8517BA

Q36225516-861DE656-5805-4DD5-AA78-0E664A1E0BFE

Q36225516-CD825F58-1A7D-4652-8F26-C3F4A86AEC39

Q36225516-F0E31A92-72E5-4491-986C-7060AFE11B0B

Q36225516-FD3DCB12-715C-4947-BD4D-DDD90B0BE556

P2860

Q36225516-0AD3E99B-19DF-4668-A139-DDB437357C06

Q36225516-1AEC8216-AEF5-4424-8B20-035A1C57BCD1

Q36225516-26744E4C-406B-4634-A970-35F52AC9932E

Q36225516-29CAFBC9-FC8A-449F-87AA-D584F1980694

Q36225516-2CCB41E1-49B2-41FE-BE4D-742A243E9E15

Q36225516-4338F6A2-8D2E-4FAA-AD7E-E72C704229E0

Q36225516-450FEEB3-D146-4967-829E-71971720E367

Q36225516-46EFEA30-B4B3-4A8F-98B9-C53C9F5E2B4A

Q36225516-4802A583-504B-4EAF-B66D-1BD4DEFE5D3E

Q36225516-4A6A2487-B9F9-4660-909F-8F35C41A9271

P304

Q36225516-5D1E5253-84CC-4258-A692-3FB95348E240

P31

Q36225516-5D7A6270-6D03-4742-8EE3-47BD5F1A97E6

P356

Q36225516-78196C15-C90C-4897-8342-DD7601915AF5

P407

Q36225516-301A0449-04A0-4C38-9961-67E082F4E92E

P433

Q36225516-991E2A51-EAA4-45C3-BF83-8E75F3A8C5AE

P478

Q36225516-75D457D7-1D87-43E0-99F3-F77D94016A4C

P50

Q36225516-187C3F63-1A96-4384-BCBF-04E4D19FB2AB

P577

Q36225516-C414BFAF-84D9-4C12-BFEC-7F2E682D9757

P5875

Q36225516-3EC75277-E56B-42C7-9FF7-53F1722EAF67

P698

Q36225516-E4EA5979-4A20-4D79-95C1-6179F23ACCB0

P921

Q36225516-A29A7432-76AB-4022-A562-9BB1D130FC5E

P932

Q36225516-7B4F2804-BF64-43DD-A381-218CF7E67F0C

P356

THX.2006.072777

P1433

P1476

Characterisation of phenotypes ...... obstructive pulmonary disease

@en

P2093

Hironi Makita

http://www.w3.org/2001/XMLSchema#string

Hokkaido COPD Cohort Study Group

http://www.w3.org/2001/XMLSchema#string

Katsura Nagai

http://www.w3.org/2001/XMLSchema#string

Masaru Hasegawa

http://www.w3.org/2001/XMLSchema#string

Nobuyuki Hizawa

http://www.w3.org/2001/XMLSchema#string

Tomoko Betsuyaku

http://www.w3.org/2001/XMLSchema#string

Yasuyuki Nasuhara

http://www.w3.org/2001/XMLSchema#string

Yoko Ito

http://www.w3.org/2001/XMLSchema#string

Yuya Onodera

http://www.w3.org/2001/XMLSchema#string

P2860

Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper

The nature of small-airway obstruction in chronic obstructive pulmonary disease

Chronic cough due to chronic bronchitis: ACCP evidence-based clinical practice guidelines.

A novel polymorphism in secretory phospholipase A2-IID is associated with body weight loss in chronic obstructive pulmonary disease.

Bronchodilator reversibility testing in chronic obstructive pulmonary disease

The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease.

COPD in Japan: the Nippon COPD Epidemiology study.

The emphysematous and bronchial types of chronic airways obstruction. A clinicopathological study of patients in London and Chicago.

Pathophysiology of airflow limitation in chronic obstructive pulmonary disease.

Lung structure and function in cigarette smokers

P304

932-937

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/THX.2006.072777

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

62

http://www.w3.org/2001/XMLSchema#string

P50

Masaharu Nishimura

P577

2007-06-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6264608

http://www.w3.org/2001/XMLSchema#string

P698

17573447

http://www.w3.org/2001/XMLSchema#string

P921

chronic obstructive pulmonary disease

P932

2117136

http://www.w3.org/2001/XMLSchema#string